non-conforming pz-cel surgical application to rdeb wounds
non-conforming pz-cel surgical application to rdeb wounds: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Lead developer: ABEONA THERAPEUTICS INC. (ABEO)
Development Pipeline (1)
| Company | Phase |
|---|---|
| ABEONA THERAPEUTICS INC. (ABEO) | Phase 4 |
Clinical Trials (1)
Phase 4 Master Protocol for Patients Prescribed Prademagene Zamikeracel for the Treatment of Wounds
Frequently asked questions
Who is developing non-conforming pz-cel surgical application to rdeb wounds?
non-conforming pz-cel surgical application to rdeb wounds is being developed by ABEONA THERAPEUTICS INC..
How many clinical trials involve non-conforming pz-cel surgical application to rdeb wounds?
BioSniper tracks 1 clinical trial involving non-conforming pz-cel surgical application to rdeb wounds.
Analyze ABEONA THERAPEUTICS INC. & non-conforming pz-cel surgical application to rdeb wounds with AI
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
- 200 free AI credits / month to run live multi-agent analysis
- Watchlist, catalyst alerts & the biotech event calendar
- Full pipeline, financials & FDA data on every company